Literature DB >> 10319190

Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment.

P Glue1, R P Clement.   

Abstract

1. The cytochrome P450 enzyme family is one of the major drug metabolizing systems in man. 2. Factors such as age, gender, race, environment, and drug treatment may have considerable influence on the activity of these enzymes. 3. There are now well-established in vitro techniques for assessing the role of specific cytochrome P450 enzymes in the metabolism of drugs, as well as the inhibitory or inducing effects of drugs on enzyme activity. In vitro data have been utilized to predict clinical outcomes (i.e., pharmacokinetic interactions), with close correlations between in vitro and in vivo data. 4. This information can be of considerable practical assistance to clinicians, to help with rational prescribing or to prevent or minimize the potential for drug interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10319190     DOI: 10.1023/a:1006993631057

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  74 in total

Review 1.  Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity.

Authors:  C S Yang; J F Brady; J Y Hong
Journal:  FASEB J       Date:  1992-01-06       Impact factor: 5.191

2.  Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification.

Authors:  M Heim; U A Meyer
Journal:  Lancet       Date:  1990-09-01       Impact factor: 79.321

3.  Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications.

Authors:  L Bertilsson; B Mellström; F Sjökvist; B Mårtenson; M Asberg
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

4.  Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.

Authors:  Q Y Yue; J O Svensson; C Alm; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

5.  Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.

Authors:  K L Kunze; L C Wienkers; K E Thummel; W F Trager
Journal:  Drug Metab Dispos       Date:  1996-04       Impact factor: 3.922

6.  Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake.

Authors:  N Perrot; B Nalpas; C S Yang; P H Beaune
Journal:  Eur J Clin Invest       Date:  1989-12       Impact factor: 4.686

Review 7.  Cytochromes P450 expression systems.

Authors:  F J Gonzalez; K R Korzekwa
Journal:  Annu Rev Pharmacol Toxicol       Date:  1995       Impact factor: 13.820

8.  Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.

Authors:  M V Relling; J S Lin; G D Ayers; W E Evans
Journal:  Clin Pharmacol Ther       Date:  1992-12       Impact factor: 6.875

9.  Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.

Authors:  G Engel; U Hofmann; H Heidemann; J Cosme; M Eichelbaum
Journal:  Clin Pharmacol Ther       Date:  1996-06       Impact factor: 6.875

10.  Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects.

Authors:  T Walle; U K Walle; T D Cowart; E C Conradi
Journal:  Clin Pharmacol Ther       Date:  1989-09       Impact factor: 6.875

View more
  12 in total

1.  Human liver mitochondrial cytochrome P450 2D6--individual variations and implications in drug metabolism.

Authors:  Michelle Cook Sangar; Hindupur K Anandatheerthavarada; Weigang Tang; Subbuswamy K Prabu; Martha V Martin; Miroslav Dostalek; F Peter Guengerich; Narayan G Avadhani
Journal:  FEBS J       Date:  2009-05-11       Impact factor: 5.542

2.  Mice Fed a High-Fat Diet Supplemented with Resistant Starch Display Marked Shifts in the Liver Metabolome Concurrent with Altered Gut Bacteria.

Authors:  Dorothy A Kieffer; Brian D Piccolo; Maria L Marco; Eun Bae Kim; Michael L Goodson; Michael J Keenan; Tamara N Dunn; Knud Erik Bach Knudsen; Roy J Martin; Sean H Adams
Journal:  J Nutr       Date:  2016-11-02       Impact factor: 4.798

Review 3.  Patient counseling about herbal-drug interactions.

Authors:  Md Sarfaraj Hussain
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-07-03

4.  Quantitative drug interactions prediction system (Q-DIPS): a dynamic computer-based method to assist in the choice of clinically relevant in vivo studies.

Authors:  P Bonnabry; J Sievering; T Leemann; P Dayer
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women.

Authors:  Bruce P Burnett; Lakshmi Pillai; Alessandra Bitto; Francesco Squadrito; Robert M Levy
Journal:  Int J Womens Health       Date:  2011-05-09

6.  Potential Drug-Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study.

Authors:  Ferit Kuscu; Aslihan Ulu; Ayse S Inal; Bedia M Suntur; Hande Aydemir; Serdar Gul; Kenan Ecemis; Suheyla Komur; Behice Kurtaran; Ozlem Ozkan Kuscu; Yesim Tasova
Journal:  Med Sci Monit       Date:  2018-06-20

7.  Promising phytochemicals of traditional Himalayan medicinal plants against putative replication and transmission targets of SARS-CoV-2 by computational investigation.

Authors:  Jagadish Natesh; Priya Mondal; Bhavjot Kaur; Abdul Ajees Abdul Salam; Srikaa Kasilingam; Syed Musthapa Meeran
Journal:  Comput Biol Med       Date:  2021-04-20       Impact factor: 6.698

8.  Simultaneous determination of cytochrome P450 1A, 2A and 3A activities in porcine liver microsomes.

Authors:  Monika Johansson; Jana Tomankova; Shengjie Li; Galia Zamaratskaia
Journal:  Interdiscip Toxicol       Date:  2012-09

9.  Pharmacovigilance: effects of herbal components on human drugs interactions involving cytochrome P450.

Authors:  Akansha Saxena; Kumar Parijat Tripathi; Sudeep Roy; Feroz Khan; Ashok Sharma
Journal:  Bioinformation       Date:  2008-12-31

10.  Comparison of metabolic pathways of different α-N-heterocyclic thiosemicarbazones.

Authors:  Karla Pelivan; Lisa M Frensemeier; Uwe Karst; Gunda Koellensperger; Petra Heffeter; Bernhard K Keppler; Christian R Kowol
Journal:  Anal Bioanal Chem       Date:  2018-02-23       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.